Clinical Trial Update: Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer [Phase 1]

View source ↗

Summary

A completed Phase 1 trial assessed combining the monoclonal antibody A1G4 with Bacillus Calmette-Guérin (BCG) in patients with neuroblastoma or sarcoma to evalu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma
• Sarcoma

Drugs mentioned

• A1G4
• BCG (Bacillus Calmette-Guérin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Neuroblastoma, Sarcoma | Phase 1 | Status: COMPLETED